Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03636022 · ClinicalTrials.gov registry record · NA
Virtual Reality System for Anxiety and OCD
A NA study, sponsored by Minnesota HealthSolutions.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT03636022 is a NA study that has completed, run by Minnesota HealthSolutions. The registered enrollment target is 45 participants.
The verdict
NCT03636022, a NA study, has completed, sponsored by Minnesota HealthSolutions.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
Cognitive Behavioral Therapy with fear provoking exposures is the most effective therapy for anxiety disorders. The investigators aim to enhance this therapy with the use of virtual reality exposures. The human subjects study will test the effects of using VR for exposures compared to traditional imaginal exposures on anxiety symptom improvement, functioning, child engagement in an response to exposures, completion of exposure homework between treatment sessions, and length of treatment in weeks and length of treatment among children with anxiety disorders and/or obsessive compulsive disorder. The funding award supports the development of the technology and the human subjects study. The subcontract to Mayo supports expert input to identify clinically relevant content for therapeutic videos on the VR system and the human subjects study to test the VR system.
Interventions
- OTHER Control
- OTHER VR System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2020-11-01 |
| Est. Completion | 2023-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03636022
The ClinicalTrials.gov registry entry for NCT03636022 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Minnesota HealthSolutions, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT03636022 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03636022 about?
NCT03636022 is a clinical study titled "Virtual Reality System for Anxiety and OCD". Cognitive Behavioral Therapy with fear provoking exposures is the most effective therapy for anxiety disorders. The investigators aim to enhance this therapy with the use of virtual reality exposures. The human subjects study will test the effects of using VR for exposures compared to traditional im...
What is the current status of trial NCT03636022?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2020-11-01. Estimated completion is 2023-05-31.
What interventions are being tested in trial NCT03636022?
The interventions under investigation include: Control (OTHER), VR System (OTHER).
Who is sponsoring clinical trial NCT03636022?
This trial is sponsored by Minnesota HealthSolutions, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.